Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 2
1989 1
1990 1
1991 2
1993 3
1994 2
1995 2
1997 1
1998 1
1999 2
2000 4
2002 2
2003 7
2004 6
2005 4
2006 9
2007 8
2008 9
2009 10
2010 9
2011 12
2012 16
2013 20
2014 9
2015 9
2016 13
2017 25
2018 26
2019 26
2020 42
2021 44
2022 18
Text availability
Article attribute
Article type
Publication date

Search Results

312 results
Results by year
Filters applied: . Clear all
Page 1
Bispecific Antibodies for Triple Negative Breast Cancer.
Dees S, Ganesan R, Singh S, Grewal IS. Dees S, et al. Among authors: ganesan r. Trends Cancer. 2021 Feb;7(2):162-173. doi: 10.1016/j.trecan.2020.09.004. Epub 2020 Oct 8. Trends Cancer. 2021. PMID: 33041246 Review.
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
León-Castillo A, Gilvazquez E, Nout R, Smit VT, McAlpine JN, McConechy M, Kommoss S, Brucker SY, Carlson JW, Epstein E, Rau TT, Soslow RA, Ganesan R, Matias-Guiu X, Oliva E, Harrison BT, Church DN, Gilks CB, Bosse T. León-Castillo A, et al. Among authors: ganesan r. J Pathol. 2020 Mar;250(3):312-322. doi: 10.1002/path.5373. Epub 2020 Jan 12. J Pathol. 2020. PMID: 31829447 Free PMC article.
Elongated neutrophil-derived structures are blood-borne microparticles formed by rolling neutrophils during sepsis.
Marki A, Buscher K, Lorenzini C, Meyer M, Saigusa R, Fan Z, Yeh YT, Hartmann N, Dan JM, Kiosses WB, Golden GJ, Ganesan R, Winkels H, Orecchioni M, McArdle S, Mikulski Z, Altman Y, Bui J, Kronenberg M, Chien S, Esko JD, Nizet V, Smalley D, Roth J, Ley K. Marki A, et al. Among authors: ganesan r. J Exp Med. 2021 Mar 1;218(3):e20200551. doi: 10.1084/jem.20200551. J Exp Med. 2021. PMID: 33275138 Free PMC article.
Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.
Bosse T, Nout RA, McAlpine JN, McConechy MK, Britton H, Hussein YR, Gonzalez C, Ganesan R, Steele JC, Harrison BT, Oliva E, Vidal A, Matias-Guiu X, Abu-Rustum NR, Levine DA, Gilks CB, Soslow RA. Bosse T, et al. Among authors: ganesan r. Am J Surg Pathol. 2018 May;42(5):561-568. doi: 10.1097/PAS.0000000000001020. Am J Surg Pathol. 2018. PMID: 29505428 Free PMC article.
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data.
Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S, Brockbank EC, Bosse T, de Azevedo Focchi GR, Ganesan R, Glasspool RM, Howitt BE, Kim HS, Lee JY, Le ND, Lockley M, Manchanda R, Mandalia T, McCluggage WG, McNeish I, Midha D, Srinivasan R, Tan YY, van der Griend R, Yunokawa M, Zannoni GF; HGSC CRS Collaborative Network (Supplementary 1), Singh N. Cohen PA, et al. Among authors: ganesan r. Gynecol Oncol. 2019 Aug;154(2):441-448. doi: 10.1016/j.ygyno.2019.04.679. Epub 2019 May 19. Gynecol Oncol. 2019. PMID: 31118141 Free article. Review.
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.
Gore M, Hackshaw A, Brady WE, Penson RT, Zaino R, McCluggage WG, Ganesan R, Wilkinson N, Perren T, Montes A, Summers J, Lord R, Dark G, Rustin G, Mackean M, Reed N, Kehoe S, Frumovitz M, Christensen H, Feeney A, Ledermann J, Gershenson DM. Gore M, et al. Among authors: ganesan r. Gynecol Oncol. 2019 Jun;153(3):541-548. doi: 10.1016/j.ygyno.2019.03.256. Epub 2019 Apr 18. Gynecol Oncol. 2019. PMID: 31005287 Free PMC article. Clinical Trial.
New Directions in Vulvar Cancer Pathology.
Williams A, Syed S, Velangi S, Ganesan R. Williams A, et al. Among authors: ganesan r. Curr Oncol Rep. 2019 Aug 15;21(10):88. doi: 10.1007/s11912-019-0833-z. Curr Oncol Rep. 2019. PMID: 31418120 Review.
312 results